This event will present the most updated and original content on communicating the cost and budget effectiveness of high-value drugs to key stakeholders in a high potential and exciting emerging region.
- Understand how medical affairs are at the forefront of new pharmaceutical industry commercial models and what needs to be done to maximise success.
- Discover what are the most intelligent ways to map and engage with KOLs and other prescribers, payers, patient groups, pharmacies and tomorrow’s stakeholders.
- Benchmark with experts to find out what are best practices in late-phase research, especially observational studies, patient registries and investigator initiated studies.
- Discover how medical liaisons, in support of commercial teams, are crucial to the communication of effectiveness, safety and cost-effectiveness.
To request the full agenda please follow this link.